A platform trial in practice: adding a new experimental research arm to the ongoing confirmatory FLAIR trial in chronic lymphocytic leukaemia
出版年份 2021 全文链接
标题
A platform trial in practice: adding a new experimental research arm to the ongoing confirmatory FLAIR trial in chronic lymphocytic leukaemia
作者
关键词
-
出版物
Trials
Volume 22, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-01-08
DOI
10.1186/s13063-020-04971-2
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Effective delivery of Complex Innovative Design (CID) cancer trials—A consensus statement
- (2020) Sarah P. Blagden et al. BRITISH JOURNAL OF CANCER
- Designs for adding a treatment arm to an ongoing clinical trial
- (2020) Maxine Bennett et al. Trials
- Including non-concurrent control patients in the analysis of platform trials: is it worth it?
- (2020) Kim May Lee et al. BMC Medical Research Methodology
- Mind the gap? The platform trial as a working environment
- (2019) Liz Morrell et al. Trials
- This is a platform alteration: a trial management perspective on the operational aspects of adaptive and platform and umbrella protocols
- (2019) Francesca Schiavone et al. Trials
- Changing platforms without stopping the train: experiences of data management and data management systems when adapting platform protocols by adding and closing comparisons
- (2019) Dominic Hague et al. Trials
- Ibrutinib Plus Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: The CLARITY Study
- (2019) Peter Hillmen et al. JOURNAL OF CLINICAL ONCOLOGY
- Adaptive platform trials: definition, design, conduct and reporting considerations
- (2019) NATURE REVIEWS DRUG DISCOVERY
- Avoiding bias in trials in which allocation ratio is varied
- (2018) Douglas G Altman JOURNAL OF THE ROYAL SOCIETY OF MEDICINE
- Randomized trial of ibrutinib versus ibrutinib plus rituximab in patients with chronic lymphocytic leukemia
- (2018) Jan A. Burger et al. BLOOD
- Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both
- (2017) Janet Woodcock et al. NEW ENGLAND JOURNAL OF MEDICINE
- Assessment of ibrutinib plus rituximab in front-line CLL (FLAIR trial): study protocol for a phase III randomised controlled trial
- (2017) Laura Collett et al. Trials
- Recommendations on multiple testing adjustment in multi-arm trials with a shared control group
- (2016) Dena R Howard et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- The Platform Trial
- (2015) Scott M. Berry et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study
- (2015) A C Rawstron et al. LEUKEMIA
- Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
- (2015) Jan A. Burger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adding a treatment arm to an ongoing clinical trial: a review of methodology and practice
- (2015) Dena R Cohen et al. Trials
- Flexible trial design in practice - stopping arms for lack-of-benefit and adding research arms mid-trial in STAMPEDE: a multi-arm multi-stage randomized controlled trial
- (2012) Matthew R Sydes et al. Trials
- Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial
- (2010) M Hallek et al. LANCET
- Multi-Arm Clinical Trials of New Agents: Some Design Considerations
- (2008) B. Freidlin et al. CLINICAL CANCER RESEARCH
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started